CynergisTek Reports Healthcare Data Security Is a Patient Safety Issue

Multiple clients rely on CynergisTek for cyber resilience strategic services to continue the momentum of security programs to meet rising patient safety concerns

AUSTIN, Texas–(BUSINESS WIRE)–$CTEK #cyberresilience—CynergisTek (NYSE American: CTEK), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces an increase in both new multiple client deals and renewals with nationally recognized health systems for cyber resilience strategic services including an expanded multi-year Resilience Partner Program and Virtual CISO services.

During the COVID-19 pandemic, healthcare IT security responded to standing up remote work, telehealth, and outfitting hospitals to handle the influx of patients with COVID-19 by instituting measures to maintain business continuity and protecting against new cyber threats due to the increased threat landscape. This resulted in many existing cybersecurity projects, including consulting placed on hold, canceled, or diminished in nature. As the healthcare industry returns to a new normal, IT security investment and demand for services to shore up their defensive and offensive strategy to address the increase in cyberattacks is starting to resurface. Ponemon Institute’s recent survey of hundreds of healthcare organizations acknowledges that more than 20% of those who responded said that mortality rates have risen as a result of ransomware attacks, reinforcing that cybersecurity is a patient safety concern.

“A paradigm shift is happening in the industry, organizations recognize the need to move to become more resilient – the ability to avoid and withstand attacks which have become a regular occurrence and are now impacting patient care. CynergisTek is primed to help organizations prepare, rehearse, and validate security through its Resilience Partner Program and Virtual CISO services,” said Mac McMillan, CEO and President at CynergisTek. The company’s Resilience Partner Program is a multi-year partnership focusing on helping clients meet goals aimed to improve and maintain their security posture. Virtual CISO services provide clients with an experienced and seasoned security resource to work with the existing IT security team on special projects, filling in for a vacant CISO, remediation, project management, and board-level involvement. “Both of these services assist our clients in responding to this critical challenge and these recent renewals and expansions confirm our clients are focusing on security and appreciate the value we deliver year in and year out.”

About CynergisTek, Inc.

CynergisTek (www.cynergistek.com), is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company’s security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or Linkedin.

Cautionary Note Regarding Forward Looking Statements

This release contains certain forward-looking statements relating to the business of CynergisTek, Inc.. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company’s vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of COVID-19, including the geographic spread, the severity of the virus, the duration of the COVID-19 outbreak, actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets, and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contacts

Investor Relations Contact:

CynergisTek, Inc.

Paul Anthony

InvestorRelations@cynergistek.com

Media Contact:

Allison + Partners

Jaime Tero

415-755-8639

jaime.tero@allisonpr.com